|
|
||||||||
REVIEW
1 Department of Molecular Cardiovascular Biology, Yamaguchi University School of Medicine, Ube, Japan;
2 Department of Medicine, Center for Research in Biological Systems, University of California San Diego, San Diego, California; and
3 MGH Cardiovascular Research Center, Harvard Medical School, Boston, Massachusetts krchien{at}partners.org ysikeda{at}yamaguchi-u.ac.jp
A growing body of evidence indicates that heart failure progression is tightly associated with dysregulation of phosphorylation of Ca2+ regulators localized in the sub-cellular microdomain of the sarcoplasmic reticulum. Chemical or genetic correction of abnormalities in cardiac phosphorylation cascades is emerging as a potential target in the treatment of heart failure. Here, we review how specific kinases and phosphatases finely tune Ca2+ cycling and regulate excitation-contraction (E-C) coupling in cardiomyocytes.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |